Subject : A survey to assess demographic differences in prevalence, risk profile, diagnostic tests and follow up pattern of myocardial infarction in young adults (ROSULEAD)
Coronary artery disease (CAD) is the leading cause of mortality worldwide with close to nine million deaths annually. In the past two decades, CAD related mortality in older adults has declined however has remained static in younger individuals. In recent past, hospital admissions with acute myocardial infarction (MI) in young individuals aged 35–54 years has increased. This has been attributed to the increasing rates of adolescent tobacco consumption, smoking, obesity, lifestyle and dietary habits, diabetes and dyslipidemia. South Asian population including Indians are known to suffer from ischemic heart disease (IHD), a decade earlier than other population groups. The INTERHEART study reported that among the South Asian population subset, the mean age at first acute coronary syndrome (ACS) episode is around 53 years. The reported incidence of CAD among young Indians is 12–16% while it is only 5% in the Western population. In the South-East Asian population, most of the cases of CAD in young are dominated by ACS particularly ST Elevation Myocardial Infarction (STEMI). Data from the Indian Heart Association reflects that nearly 50% of all ACS in India occur in men less than 50 years of age while around 25 % occur in men under the age of 40 years. Global burden of diseases study reported a higher IHD mortality in Indians aged 20–54 years as compared to the United States, China and Europe.1However, when compared to their older counterparts, data from earlier registries suggest good prognosis in young adults with STEMI.
The purpose of this survey is to understand the current perceptions about prevalence, risk factors and management pattern of myocardial infarction in young adults and also help to address the current need gaps to look at potential interventions at patient level.
If you agree to participate, you will need to provide assessment response, on to the standard questionnaire form. A link will be provided for the same on your registered email address.
We trust you and we are partners in safe and effective drug therapy. In that spirit we hope you will consent to participate in this survey.
If you agree to participate in the said study, we would request you to sign and return the enclosed reply along with your visiting card for accuracy of records.
|
}}){kind=logo}
}})